Insurance Updates:  August 3

By Policy and Advocacy Brief posted 08-03-2022 17:09

  

Insurance Updates:  August 3

Each week, the AUA publishes weekly updates on the latest insurance issues pertaining to urology. This week’s update includes the release of policies regarding infertility and HCG agents.

BCBS Federal Employee Plan

BCBS Federal Employee Plan issued its new Tumor Informed Circulating Tumor DNA Testing for Cancer Management Policy stating tumor-informed circulating tumor DNA testing (Signatera) is considered not medically necessary for all indications.

Read the update.

BCBS Minnesota

BCBS Minnesota reviewed its Infertility and HCG Agents policy adding gender dysphoria as an approved indication for agents for fertility preservation, along with associated criteria.

Read the update.

BCBS North Carolina

BCBS North Carolina issued a new version of its Agents for Prostate Cancer (Enhanced and Net Results) Prior Authorization Form.

Read the update.

BCBS North Carolina issued a new version of its Agents for Prostate Cancer (Essential) Prior Authorization Form.

Read the update.

BCBS North Dakota

BCBS North Dakota reviewed its Posterior Tibial Nerve Stimulation Policy, with changes to criteria.

Read the update.

BCBS Rhode Island

BCBS Rhode Island released its draft Genetic Testing Services Policy, effective October 1.

Read the update.

Empire BCBS

Empire BCBS reviewed its Gene Expression Profiling for Bladder Cancer Policy revising the code descriptor for CPT code 0016M.

Read the update.

Noridian

Noridian retired its 4Kscore Assay (JF) (A57337) Local Coverage Article (LCA), effective June 12. This article is being retired because this is no longer within the scope of MolDX program. Noridian does not anticipate any claims for this service.

Read the update.

Noridian announced an Open Public Meeting, which will take place August 11, 2022 virtually from 2:00 p.m. to 4:00 p.m. Topics include MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer. An agenda is available. Register, here.

Read the update.

0 comments
3 views

Permalink